ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635
| ORIC Stock | USD 5.97 0.19 3.29% |
About 55% of Oric Pharmaceuticals' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Oric Pharmaceuticals suggests that some traders are interested. The current market sentiment, together with Oric Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Oric Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 01, 2024 -- ORIC Pharmaceuticals, Inc. , a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on November 1, 2024 , ORIC granted a total of 61,800 non-qualified stock options and 10,400 restricted stock units to two new non-executive employees who began their employment with ORIC in October 2024. These inducement gra
Read at finance.yahoo.com
 |
Oric Pharmaceuticals Fundamental Analysis
We analyze Oric Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oric Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oric Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Oric Pharmaceuticals is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Oric Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oric Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Oric Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Oric Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Oric Pharmaceuticals Related Equities
| IMRX | Immuneering Corp | 9.76 | ||||
| PEPG | PepGen | 7.48 | ||||
| HOWL | Werewolf Therapeutics | 2.52 | ||||
| SEER | Seer | 1.53 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.89 | ||||
| MLYS | Mineralys Therapeutics, | 0.70 | ||||
| ELVN | Enliven Therapeutics | 0.50 | ||||
| CGEM | Cullinan Oncology | 0.26 | ||||
| MOLN | Molecular Partners | 0.25 | ||||
| CELC | Celcuity LLC | 0.38 | ||||
| PMVP | Pmv Pharmaceuticals | 1.10 | ||||
| EWTX | Edgewise Therapeutics | 2.37 | ||||
| PHVS | Pharvaris | 2.40 | ||||
| ANTX | AN2 Therapeutics | 2.54 | ||||
| CCCC | C4 Therapeutics | 3.08 |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |